TERTIARY STRUCTURE DATA |
human herpesvirus 5
|
mature peptidase |
2.27 Å |
1CMV |
1CMV |
1CMV |
1CMV |
1CMV |
1CMV |
Shieh et al., 1996 |
active site His157Gln mutant |
2.20 Å |
1ID4 |
1ID4 |
1ID4 |
1ID4 |
1ID4 |
1ID4 |
Khayat et al., 2001 |
active site His157Ala mutant |
2.20 Å |
1IEC |
1IEC |
1IEC |
1IEC |
1IEC |
1IEC |
Khayat et al., 2001 |
active site His157Glu mutant |
2.00 Å |
1IED |
1IED |
1IED |
1IED |
1IED |
1IED |
Khayat et al., 2001 |
active site Ser134Ala mutant |
2.30 Å |
1IEF |
1IEF |
1IEF |
1IEF |
1IEF |
1IEF |
Khayat et al., 2001 |
active site Ser134Ala/His157Ala double mutant |
2.00 Å |
1IEG |
1IEG |
1IEG |
1IEG |
1IEG |
1IEG |
Khayat et al., 2001 |
dimer interface Ser225Tyr mutant |
2.30 Å |
1JQ6 |
1JQ6 |
1JQ6 |
1JQ6 |
1JQ6 |
1JQ6 |
Batra et al., 2001 |
dimer interface Ser225Tyr mutant; complex with BILC 408 inhibitor |
3.00 Å |
1JQ7 |
1JQ7 |
1JQ7 |
1JQ7 |
1JQ7 |
1JQ7 |
Batra et al., 2001 |
Ala143Val mutant |
2.50 Å |
1LAY |
1LAY |
1LAY |
1LAY |
1LAY |
1LAY |
Qiu et al., 1996 |
complex with N-acetyl-L-valyl-3,3-dimethyl-L-alpha-aspartyl-N~4~,N~4~-dimethyl-N~1~-[(1R)-3,3,3-trifluoro-1-methyl-2-oxopropyl]-L-aspartamide |
2.50 Å |
1NJT |
1NJT |
1NJT |
1NJT |
1NJT |
1NJT |
Khayat et al., 2003 |
complex with N-(6-aminohexanoyl)-3-methyl-L-valyl-3-methyl- L-valyl-N~1~-[(2S,3S)-3-hydroxy-4-oxo-4-[(1R)- 1-phenylpropyl]aminobutan-2-yl]-N~4~,N~4~- dimethyl-L-aspartamide |
2.70 Å |
1NJU |
1NJU |
1NJU |
1NJU |
1NJU |
1NJU |
Khayat et al., 2003 |
complex with N-acetyl-L-valyl-3,3-dimethyl-L-alpha-aspartyl-N~4~,N~4~-dimethyl-N~1~-[(1R)-3,3,3-trifluoro-1-methyl-2-oxopropyl]-L-aspartamide |
2.60 Å |
1NKK |
1NKK |
1NKK |
1NKK |
1NKK |
1NKK |
Khayat et al., 2003 |
complex with N-(6-aminohexanoyl)-3-methyl-L-valyl-3-methyl-L-valyl-N~4~,N~4~-dimethyl-N~1~-[(1R)-1-methyl-2,3-dioxo-3-[(1S)-1- phenylpropyl]aminopropyl]-L-aspartamide |
2.70 Å |
1NKM |
1NKM |
1NKM |
1NKM |
1NKM |
1NKM |
Khayat et al., 2003 |
dimer |
2.00 Å |
1WPO |
1WPO |
1WPO |
1WPO |
1WPO |
1WPO |
Tong et al., 1996 |
complex with des-amino-t-butyl-Gly-t-butyl-Gly-phenylAsn-Ala-BAC inhibitor |
2.70 Å |
2WPO |
2WPO |
2WPO |
2WPO |
2WPO |
2WPO |
Tong et al., 1998 |